Aprea Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year One
Aprea Therapeutics, Inc. (APRE) had Lessee, Operating Lease, Liability, to be Paid, Year One of $53.22 thousand as of 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2022-11-09
- 2022-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $53.22K.
- 2022-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $63.90K.
- 2022-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $63.90K.
- 2021-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $193.98K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2022-09-30 | $53.22K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $63.90K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $63.90K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $193.98K 10-K · filed 2022-03-15 |
| 2021-09-30 | $195.86K 10-Q · filed 2021-11-08 |
| 2021-06-30 | $69.56K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $67.86K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $270.82K 10-K · filed 2021-03-16 |
| 2020-09-30 | $257.95K 10-Q · filed 2020-11-06 |
| 2019-12-31 | $251.01K 10-K · filed 2020-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |